Abstract only availableProstate cancer is one of the most common forms of cancer in men. Our lab is currently investigating changes in DNA methylation that occur during cancer progression, and in response to the soy phytoestrogen genistein treatment. We analyze genome-wide methylation differences by using the mouse DMH (mouse-Differential Methylation Hybridization) assay, a form of microarray. We are specifically looking at broad sets of CpG islands, areas rich in cytosine-guanine dinucleotides, that are subject to epigenetic modifications. The hypermethylation of CpG islands is correlated with the silencing of a gene while hypomethylation is correlated with a gene being actively transcribed. We were looking for potential new oncogenes or t...
Increasing evidence suggests that aberrant DNA methylation changes may contribute to prostate cancer...
Introduction<p>The current methodology involving diagnosis of prostate cancer (PCa) relies on the pa...
A critical need in understanding the biology of prostate cancer is characterizing the molecular diff...
Abstract only availableDNA methylation alteration, in correlation with gene expression, is involved ...
The process of DNA CpG methylation has been extensively investigated for over 50 years and revealed ...
Background: Promoter and 59 end methylation regulation of tumour suppressor genes is a common featur...
DNA methylation is an important contributor for prostate cancer development and progression. It has ...
Altered genome methylation is a hallmark of human malignancies. In this study, high-throughput analy...
Aberrant DNA methylation in gene promoters causes gene silencing and is a common event in prostate c...
DNA methylation is one of the most important epigenetic mechanisms in regulating gene expression. Ge...
DNA cytosine methylation is an important epigenetic modification that plays a key role in demarcatio...
Many differentially methylated genes have been identified in prostate cancer (PCa), primarily using ...
Prostate cancer (PCa) is the most common malignancy in men. Epigenetic alterations, including DNA me...
SummaryA critical need in understanding the biology of prostate cancer is characterizing the molecul...
Early diagnosis represents an effective way to improve patient prognosis in cancer. New opportunitie...
Increasing evidence suggests that aberrant DNA methylation changes may contribute to prostate cancer...
Introduction<p>The current methodology involving diagnosis of prostate cancer (PCa) relies on the pa...
A critical need in understanding the biology of prostate cancer is characterizing the molecular diff...
Abstract only availableDNA methylation alteration, in correlation with gene expression, is involved ...
The process of DNA CpG methylation has been extensively investigated for over 50 years and revealed ...
Background: Promoter and 59 end methylation regulation of tumour suppressor genes is a common featur...
DNA methylation is an important contributor for prostate cancer development and progression. It has ...
Altered genome methylation is a hallmark of human malignancies. In this study, high-throughput analy...
Aberrant DNA methylation in gene promoters causes gene silencing and is a common event in prostate c...
DNA methylation is one of the most important epigenetic mechanisms in regulating gene expression. Ge...
DNA cytosine methylation is an important epigenetic modification that plays a key role in demarcatio...
Many differentially methylated genes have been identified in prostate cancer (PCa), primarily using ...
Prostate cancer (PCa) is the most common malignancy in men. Epigenetic alterations, including DNA me...
SummaryA critical need in understanding the biology of prostate cancer is characterizing the molecul...
Early diagnosis represents an effective way to improve patient prognosis in cancer. New opportunitie...
Increasing evidence suggests that aberrant DNA methylation changes may contribute to prostate cancer...
Introduction<p>The current methodology involving diagnosis of prostate cancer (PCa) relies on the pa...
A critical need in understanding the biology of prostate cancer is characterizing the molecular diff...